Artera has secured CE marking under the European Union In Vitro Diagnostic Regulation (EU IVDR) for its ArteraAI prostate ...

An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

Artera, a developer of multimodal AI-based prognostic and predictive cancer tests, announced today that it was granted CE ...

Learn about prostate cancer risks, warning signs, and the importance of PSA testing for early detection and treatment.

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

Prostate cancer affects one in eight men in the U.S. over their lifetime, which is the same rate as women and breast cancer.

Researchers at Queen Mary University of London have found that the likelihood of prostate cancer overdiagnosis—the detection ...

A digital rectal exam (DRE) is a way to check for signs of prostate cancer. For this exam a physician inserts a gloved, lubricated finger into your rectum to: Feel your prostate gland Assess the ...

Please provide your email address to receive an email when new articles are posted on . Nearly half of people diagnosed with advanced cancer between 2018 and 2022 did not undergo next-generation ...

Simeon Greene, from Wolverhampton, believes 54 of his relatives may have had prostate cancer.